Malaria Hybrids: A Chronological Evolution. 
Malaria, an upsetting malaise caused by a diverse class of Plasmodium species affects about 40% of the world's population.  The distress associated with it has reached colossal scales owing to the development of resistance to most of the clinically available agents.  Hence, the search for newer molecules for malaria treatment and cure is an incessant process.  After the era of a single molecule for malaria treatment ended, there was an advent of combination therapy.  However, lately there had been reports of the development of resistance to many of these agents as well.  Subsequently, at present most of the peer groups working on malaria treatment aim to develop novel molecules, which may act on more than one biological processes of the parasite life cycle, and these scaffolds have been aptly termed as Hybrid Molecules or Double Drugs.  These molecules may hold the key to hitherto unknown ways of showing a detrimental effect on the parasite.  This review enlists a few of the recent advances made in malaria treatment by these hybrid molecules in a sequential manner.